ciladopa has been researched along with mesulergine in 1 studies
Studies (ciladopa) | Trials (ciladopa) | Recent Studies (post-2010) (ciladopa) | Studies (mesulergine) | Trials (mesulergine) | Recent Studies (post-2010) (mesulergine) |
---|---|---|---|---|---|
11 | 3 | 0 | 265 | 10 | 28 |
Protein | Taxonomy | ciladopa (IC50) | mesulergine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0019 | |
5-hydroxytryptamine receptor 7 | Homo sapiens (human) | 0.205 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0021 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0052 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0021 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lang, AE | 1 |
1 review(s) available for ciladopa and mesulergine
Article | Year |
---|---|
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines | 1987 |